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Analysis of exoglucanase activity accumulated by set mutants from Saccharomyces cerevisiae rev aled the presence of 
two ionic forms of the major exoglucanase (exo II) secreted into the culture medium. From the accumulation pattern 
of representative set mutants and the carbohydrate composition it appears that the less acidic form is converted into 
the more acidic one by addition of one phosphate to one of the oligosaccharide cores as the enzyme progresses through 
the secretory pathway. Exoglucanase I, the heavier isoenzyme, was not accumulated by the mutants. Accordingly, it 
should arise from exoglucanase II after the execution point of secl mutation. 
Exoglucanase; Secretory pathway; Ionic form; (Yeast) 
1. INTRODUCTION 
Saccharomyces cerevisiae secretes two exogluca- 
nases into culture media [l-3]. Recent results from 
this laboratory have indicated that both isoen- 
zymes share a very similar, if not identical, protein 
portion [3] and accordingly there exists the possi- 
bility that they are products of the same or related 
genes. The final forms would arise from differen- 
tial modifications (glycosylation?) of the primary 
gene product during its transport to the cell sur- 
face. This hypothesis is further supported by the 
fact that the carbohydrate content of the major ex- 
oglucanase (exoglucanase II) is 1 l- 14%) whereas 
that of the minor isoenzyme (exoglucanase I) ex- 
ceeded 40% [4]. 
We have also shown [5] that exoglucanase activi- 
ty follows the secretory pathway defined by set 
mutants isolated by Novick et al. [6]. This feature 
makes it possible to investigate the step of the 
pathway at which exoglucanase I, the heavier en- 
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zyme, is first detected, by analysis of the molecules 
accumulated in representative set mutants blocked 
at specific stages of the secretory pathway. 
Here, we show that independently of the mutant 
used, only variants of exoglucanase II, the lighter 
enzyme, are accumulated inside the cells. In addi- 
tion, it was found that two ionic forms of this ex- 
oglucanase account for the intracellular pool of 
secretory exoglucanase. 
2. MATERI,ALS AND METHODS 
Goa anti-rabbit IgG antibodies coupled to peroxidase were 
from Bio-Rad. Other chemicals were obtained as in [3]. 
2.1. Microorganisms and culture conditions 
S. cerevisiae haploid strain X2180-1A and set mutants 
blocked in transport of secretory and plasma membrane pro- 
teins from the ER (secl8), Golgi body (sec7) and in the transport 
of secretory vesicles (secl) were supplied by Dr Schekman 
(University of California, Berkeley). They were grown as in [5]. 
These mutants accumulate secretory products at the indicated 
stages of the secretory pathway when incubated at the restrictive 
temperature of 37’C. 
2.2. Zon-exchange chromatography 
Dialyzed samples were applied to a column (6 x 1.2 cm) of 
DEAE-Bio-Gel A equilibrated at 4°C with 25 mM acetate buf- 
fer, pH 5.2, and eluted with 400 ml of a linear gradient of NaCl 
(O-O.5 M in acetate buffer) at a flow rate of 25 ml/h. Fractions 
of 4 ml were collected. 
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2.3. Immunoblots 
Proteins subjected to electrophoresis were electrophoretically 
transferred to nitrocellulose filters [7]. The filters were then in- 
cubated in blocking solution (3% BSA in TBS) for 1 h at 37°C. 
Antibody binding was carried out with 100~1 of the purified 1gG 
fraction 14) in TBS containing 0.05% Tween 20 (TBS-T) and 1% 
BSA for 2 h at 37°C under gentle shaking. Nitrocellulose filters 
were washed once with TBS-T, twice with TBS-T containing 
1 M NaCl and once with TBS-T, each time for 10 min. Paper- 
bound antibodies were detected by incubation of commercial 
goat anti-rabbit IgG antibodies coupled to peroxidase in TBS 
containing 1% BSA for 1 h at 37°C. After washing with TBS-T 
buffer, filters were incubated until color development with a 
solution containing TBS (100 ml), methanol (20 ml), 
4-chloro-1-naphthol(60 mg) and hydrogen peroxide (60~1 from 
30 volume commercial solution). The reaction was stopped by 
dipping the filter in distilled water. 
2.4. Other methods 
Transformation of cells in protoplasts, separation of soluble 
and membrane-bound forms of exoglucanase and enzymatic 
assays were carried out as in [8]. Purification of exoglucanases 
I and II, endo H treatment, PAGE, SDS-PAGE and prepara- 
tion and purification of antibodies against he protein portion 
of exoglucanase II have been described [3,4]. 
3. RESULTS 
All the exoglucanase activity accumulated by set 
mutants at the restrictive temperature is found in 
the high-speed supernatant from homogenized pro- 
toplast lysates [5]. Aliquots of these supernatants 
(0.1 U exoglucanase) derived from secl8, sec7 and 
secl cells, which had accumulated secretory 
products for 2 h at the restrictive temperature, 
were subjected to SDS-PAGE. Proteins were then 
transferred to nitrocellulose filters and exoglucan- 
ase detected with specific antibodies. In all cases 
only one protein band, migrating at the level of ex- 
oglucanase II, was detected, whereas no traces of 
exoglucanase I could be visualized (fig.1). Pellets 
from the high-speed centrifugation were also 
analyzed similarly. In this case, immunodetection 
revealed the presence of a series of bands of low 
molecular mass whose relationship to secreted ex- 
oglucanases i  at present uncertain. Since the detec- 
tion of these bands required the use of large 
amounts of membranes and long incubation times 
with peroxidase, we suspect that they represent 
non-specific material. However, even under these 
conditions no traces of exoglucanase I were de- 
tected either (fig. 1). 
The failure to detect exoglucanase I inside the 
mutant cells was at first attributed to its low level, 
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Fig. 1. Immunoblot analysis of exoglucanase accumulated by set 
mutants. Secl (lanes 1,4), sec7 (lanes 2,s) and secl8 (lanes 3,6) 
cells were incubated at 37°C for 2 h and transformed in 
protoplasts. These were lysed, homogenized and centrifuged at 
high speed to obtain supematant (lanes 4-6) and pellet (lanes 
l-3) fractions. Aliquots of these fractions were electrophoresed 
on an SDS-80/o polyacrylamide gel, transferred to nitrocellulose 
and immunodetected. Lane 7: immunodetection of purified 
exoglucanase I and II. 
since this isoenzyme accounts for only about 10% 
of the total activity present in the culture medium 
[3,4] (see also fig.2d). Accordingly, we prepared 
greater amounts of exoglucanase (3 U) from mu- 
tant cells incubated for 2 h at the restrictive temp- 
erature. Since both isoenzymes are easily separated 
by ion-exchange chromatography, high-speed 
supernatants from protoplast lysates were frac- 
tionated in DEAE-Bio-Gel A. Regardless of the 
mutant used two peaks of activity were always ap- 
parent (fig.aa-c). The second peak (B) eluted at the 
same position as the exoglucanase II present in the 
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Fig.2. Separation of two ionic forms of the exoglucanase 
accumulated by set mutants at 37°C. Soluble fractions of 
protoplasts lysates from ~18 (a), sec7 (b) and secl (c) obtained 
as described in fig.1 (l-3 units of activity) were applied to the 
DEAE-Bio-Gel column and eluted as indicated in section 2. The 
profile of the exoglucanase activity secreted by wild-type cells 
into the culture medium is represented in d. 
culture medium (0.21 M NaCl), whereas the first 
(A) eluted at a salt concentration (0.14 M) very 
close, but not identical, to that calculated for ex- 
oglucanase I (0.13 M NaCl). In addition, exo- 
glucanase I always eluted as a wide peak (fig.2d) 
which contrasted with peak A which was very 
sharp. 
Fig.3. Immunoblot analysis of the ionic forms of exoglucanase 
accumulated by set mutant cells. Aliquots of the material 
included under peaks A and B from fig.2 were subjected to SDS- 
PAGE and immunodetected as in fig. 1. Purified exoglucanase 
II was used as a control. In each case half of the sample was 
treated with endo H. 
The ratio between peaks A and B in terms of en- 
zyme activity decreased as the block in the secre- 
tory pathway was more advanced. Thus, whereas 
in secl8, and ER-blocked mutant, peak A ac- 
counted for most of the total activity, nearly 90% 
of the activity accumulated by secl , which is block- 
ed at the level of secretory vesicles, corresponded to 
peak A. Sec7, which is blocked at an intermediate 
step of the secretory pathway (Golgi body), ac- 
cumulated similar proportions of both peaks. 
of both exoglucanases [3]. Surprisingly, no ex- 
oglucanase I was accumulated inside any of the 
mutant cells. 
Since both forms A and B appear to differ in 
charge we tried to resolve them in non-denaturing 
PAGE. This technique also failed to provide a 
useful tool for a rapid analysis of the molecules ac- 
cumulated by mutant cells. 
4. DISCUSSION 
Fractions corresponding to peaks A and B of The major exoglucanase secreted by S. cerevisiue 
each mutant were pooled separately and an aliquot (exoglucanase II) containst two N-glycosidically 
treated with endo H. Thereafter, samples were linked oligosaccharide cores [9]. One is neutral 
prepared for SDS-PAGE and the corresponding whereas the other is acidic due to the presence of a 
immunoblot was obtained. As shown in fig.3 the phosphate. The higher carbohydrate content of ex- 
different exoglucanase forms from the DEAE-Bio- oglucanase I compared with exoglucanase II raises 
Gel column exhibited the same electrophoretic the suspicion that the former arises from the latter 
mobility, which coincided with that of mature ex- by addition of an outer carbohydrate chain to one 
oglucanase II purified from the culture medium. or both oligosaccharide cores. Since in other 
Moreover, all the glycoproteins were equally glycoproteins this addition seems to occur at the 
susceptible to endo H, generating a product which level of the Golgi body [lo,1 11, it would then be 
has been characterized as the deglycosylated form possible to detect exoglucanase I in mutants 
:: 
Mutant set 18 set 7 set 1 
Peak 2 AABBAABBAABB w 
EndoH -+-+-+-+-+-+-+ 
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blocked at this step or in a further stage of the 
secretory pathway. Our results indicate, however, 
that even secl, a mutant blocked at the level of 
secretory vesicles, does not accumulate this isoen- 
zyme. All the activity included under peak A of this 
mutant, i.e. the best candidate for representing 
exoglucanase I, was identified as exoglucanase II. 
In an effort to detect exoglucanase I inside the 
cells we investigated whether it was present in mem- 
brane fractions of mutants and wild-type cells, but 
again the results were negative. Accordingly, it 
should arise from exoglucanase II. This conclusion 
is in agreement with our previous suggestion that 
both exoglucanases share the same protein portion 
and thus are products of a single gene [4]. In addi- 
tion, whatever the modification implied in the con- 
version of exoglucanase II into exoglucanase I, it 
takes place after the execution point of secl muta- 
tion. In order to ascertain the nature of such a 
modification the carbohydrate moiety of exoglu- 
canase I is currently being characterized. 
Nevertheless, our efforts proved to be fruitful in 
revealing the presence of two ionic forms of ex- 
oglucanase II inside the cells. The accumulation 
pattern exhibited by representative set mutants 
strongly suggests that form A is transformed into 
form B as exoglucanase molecules progress 
through the secretory pathway. This second form 
(B) corresponds to the mature secreted exoglucan- 
ase II. On the basis of the carbohydrate composi- 
tion of exoglucanase II we suggest that the conver- 
sion of A into B occurs by addition of one phos- 
phate to one of the oligosaccharide cores present in 
the molecule. 
Such conversion would be in agreement with the 
fact that both ionic forms of exoglucanase II are 
not separated in SDS-PAGE. Purified carboxypep- 
tidase Y was also resolved on DEAE-Sephadex into 
two peaks of enzyme activity whose differences 
were attributed to a different phosphate content 
[12]. On the other hand, the failure to resolve both 
exoglucanase forms in non-denaturing PAGE in- 
dicates that the presence of one phosphate does not 
significantly modify the net charge of the protein. 
However, the projection of the carbohydrate 
chains from the enzyme surface would allow the 
acidic form to interact efficiently with the ion- 
exchange resin. 
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